Charcoal combined with silver for the treatment of chronic wounds

Wounds UK

Volumn 5, Issue 3, 2009, Pages 87-93

  Kerihuel, Jean Charles ^a  

^a Vertical   (France)

Author keywords

Actisorb dressing with silver; Activated charcoal; Bacteria; Chronic wounds

Indexed keywords

ACTIVATED CARBON; BACTERIAL TOXIN; CHARCOAL; CYTOKINE; SILVER;

ADSORPTION; BIOFILM; CHRONIC WOUND; FOAM DRESSING; HUMAN; INFLAMMATION; REVIEW; TREATMENT INDICATION; ULCER; WOUND DRESSING; WOUND FLUID;

EID: 70350180772     PISSN: 17466814     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (56)

1. Baker FS, et al (1992) Activated carbon. Kirk-Othmer Encyclopedia of Chemical Technology, 4. John Wiley and Sons, Chichester: 1015-1037
2. Bjarnsholt T, Kirketerp-Møller K, Jensen PØ, et al (2008) Why chronic wounds will not heal: a novel hypothesis. Wound Repair Regen 16(1): 2-10
3. Bowler PG, Davies BJ (1999) The microbiology of infected and noninfected leg ulcers. Int J Dermatol 38(8): 573-578
4. Bowler PG, Duerden BI, Armstrong DG (2001) Wound microbiology and associated approaches to wound management. Clin Microbiol Rev 14(2): 244-269
5. Castellano JJ, Shafii SM, Ko F, et al (2007) Comparative evaluation of silver-containing antimicrobial dressings and drugs. Int Wound J 4(2): 114-122
6. Chakravarthi A, Srinivas CR, Mathew AC (2008) Activated charcoal and baking soda to reduce odor associated with extensive blistering disorders. Indian J Dermatol Venereol Leprol 74(2): 122-124
7. Cole L, Bellomo R, Davenport P et al (2002) The effect of coupled haemofiltration and adsorption on inflammatory cytokines in an ex vivo model. Nephrol Dial Transplant 17(11): 1950-1956 (Pubitemid 35277093)
8. Davies CE, Hill KE, Wilson MJ et al (2004) Use of 16S ribosomal DNA PCR and denaturing gradient gel electrophoresis for analysis of the microfloras of healing and nonhealing chronic venous leg ulcers. J Clin Microbiol 42(8): 3549-3557
9. Davies CE, Hill KE, Newcombe RG et al (2007) A prospective study of the microbiology of chronic venous leg ulcers to reevaluate the clinical predictive value of tissue biopsies and swabs. Wound Repair Regen 15(1): 17-22
10. Ditter B, Urbaschek R, Urbaschek B (1983) Ability of various adsorbents to bind endotoxins in vitro and to prevent orally induced endotoxemia in mice. Gastroenterology 84(6): 1547-1552
11. Drucker MM, Goldhar J, Ogra PL, Neter E (1977) The effect of attapulgite and charcoal on enterotoxicity of Vibrio cholerae and Escherichia coli enterotoxins in rabbits. Infection 5(4): 211-213 (Pubitemid 8230240)
12. Du XN, Niu Z, Zhou GZ, Li ZM (1987) Effect of activated charcoal on endotoxin adsorption. Part I. An in vitro study. Biomater Artif Cells Artif Organs 15(1): 229-235
13. Ebright JR (2005) Microbiology of chronic leg and pressure ulcers: clinical significance and implications for treatment. Nurs Clin North Am 40(2): 207-216
14. Edwards R, Harding KG (2004) Bacteria and wound healing. Curr Opin Infect Dis 17(2): 91-96
15. Fleck CA (2006) Differentiating MMPs, biofilm, endotoxins, exotoxins, and cytokines. Adv Skin Wound Care 19(2): 77-81
16. Gjødsbøl K, Christensen JJ, Karlsmark T, Jørgensen B, Klein BM, Krogfelt KA (2006) Multiple bacterial species reside in chronic wounds: a longitudinal study. Int Wound J 3(3): 225-231
17. Halbert AR, Stacey MC, Rohr JB, Jopp-McKay A (1992) The effect of bacterial colonization on venous ulcer healing. Australas J Dermatol 33(2): 75-80
18. Hill KE, Davies CE, Wilson MJ et al (2003) Molecular analysis of the microflora in chronic venous leg ulceration. J Med Microbiol 52(Pt 4): 365-369
19. Howell CA, Sandeman SR, Phillips GJ et al (2006) The in vitro adsorption of cytokines by polymer-pyrolysed carbon. Biomaterials 27(30): 5286-5291
20. Jones SG, Edwards R, Thomas DW (2004) Inflammation and wound healing: the role of bacteria in the immuno-regulation of wound healing. Int J Low Extrem Wounds 3(4): 201-208
21. Kerihuel JC (2008) The economic impact of using silver releasing dressings in the management of chronic wounds: have we the required evidence to conduct such evaluations? The example of VLU. J Wound Technology 1(2): 70-73
22. Kerihuel JC, Dujardin-Detrez S (2003) Actisorb®Plus 25, a review of its clinical experience based on more than 12 000 various wounds. JPC 8(39): 3-7
23. Kirketerp-Møller K, Jensen PØ, Fazli M et al (2008) Distribution, organization, and ecology of bacteria in chronic wounds. J Clin Microbiol 46(8): 2717-2722
24. Lansdown AB (2002) Silver. I: Its antibacterial properties and mechanism of action. J Wound Care 11(4): 125-130
25. Leak K (2002) PEG site infections: a novel use for Actisorb* Silver 220. Br J Community Nurs 7(6): 321-325
26. Lee G, Anand SC, Rajendran S, Walker I (2006) Overview of current practice and future trends in the evaluation of dressings for malodorous wounds. J Wound Care 15(8): 344-346
27. Lim T, Mwipatayi B, Murray R, Sieunarine K, Abbas M, Angel D (2006) Microbiological profile of chronic ulcers of the lower limb: a prospective observational cohort study. ANZ J Surg 76(8): 688-692 (Pubitemid 44154738)
28. Maitra SK, Yoshikawa TT, Guze LB, Schotz MC (1981) Properties of binding of Escherichia coli endotoxin to various matrices. J Clin Microbiol 13(1): 49-53 (Pubitemid 11176657)
29. Malic S, Hill KE, Hayes A, Percival SL, Thomas DW, Williams DW (2009) Detection and identification of specific bacteria in wound biofilms using peptide nucleic acid fluorescent in situ hybridization (PNA FISH). Microbiology 155(Pt 8): 2603-2611
30. Marsh H, Rodríguez-Reinoso F (2006) Activated carbon. Elsevier, Oxford: 536
31. Martin JM, Zenilman JM, Lazarus GS (2009) Molecular microbiology: new dimensions for cutaneous biology and wound healing. J invest Dermatol July 23 [Epub ahead of print]
32. McDonald A, Lesage P (2006) Palliative management of pressure ulcers and malignant wounds in patients with advanced illness. J Palliat Med 9(2): 285-295
33. Millward P (1991) Comparing treatments for leg ulcers. Nurs Times 87(13): 70-72
34. Muller G, Winkler Y, Kramer A (2003) Antibacterial activity and endotoxin-binding capacity of Actisorb Silver 220. J Hosp Infect, 53(3): 211-214 (Pubitemid 38002057)
35. Mulligan CM, Bragg AJ, O'Toole OB (1986) A controlled comparative trial of Actisorb activated charcoal cloth dressings in the community. Br J Clin Pract 40(4): 145-148
36. Naka K, Watarai S, Tana, et al (2001) Adsorption effect of activated charcoal on enterohemorrhagic Escherichia coli. J Vet Med Sci 63(3): 281-285 (Pubitemid 33643452)
37. Nolan JP, McDevitt JJ, Goldmann GS, Bishop C (1975) Endotoxin binding by charged and uncharged resins. Proc Soc Exp Biol Med 149(3): 766-770
38. Ovington L (2003) Bacterial toxins and wound healing. Ostomy Wound Manage 49(7A Suppl): 8-12
39. Panuncialman J, Falanga V (2009) The science of wound bed preparation. Surg Clin North Am 89(3): 611-626
40. Penhallow K (2005) A review of studies that examine the impact of infection on the normal wound-healing process. J Wound Care 14(3): 123-126
41. Percival SL, Bowler PG, Russell D (2005) Bacterial resistance to silver in wound care. J Hosp Infect 60(1): 1-7 (Pubitemid 40485843)
42. Rhoads DD, Wolcott RD, Percival SL (2008) Biofilms in wounds: management strategies. J Wound Care 17(11): 502-508
43. Sandeman SR, Howell CA, Mikhalovsky SV et al (2008) Inflammatory cytokine removal by an activated carbon device in a flowing system. Biomaterials 29(11): 1638-1644
44. Sapico FL, Ginunas VJ, Thornhill-Joynes M, et al (1986) Quantitative microbiology of pressure sores in different stages of healing. Diagn Microbiol Infect Dis 5(1): 31-38
45. Seaman S (2006) Management of malignant fungating wounds in advanced cancer. Semin Oncol Nurs 22(3): 185-193 (Pubitemid 44163103)
46. Sibbald RG, Orsted H, Schultz GS, Coutts P, Keast D (2003) Preparing the wound bed 2003: focus on infection and inflammation. Ostomy Wound Manage 49(11): 23-51
47. Singh VA, Barbul A (2008) Bacterial biofilms in wounds. Wound Repair Regen 16(1): 1.
48. Tomljanovic-Veselski M, Zilih-Ostojic C, Topolovac Z, Desic-Brkic A, Dokuzovic (2005) Colonization of venous leg ulcers by microorganisms. Acta Dermatovenerol Croat 13(2): 104-107 (Pubitemid 41008255)
49. Thomas S, McCubbin P (2003) A comparison of the antimicrobial effects of four silver-containing dressings on three organisms. J Wound Care 12(3): 101-107
50. Verdú Soriano J, Rueda López J, Martínez Cuervo F, Soldevilla Agreda J (2004) Effects of an activated charcoal silver dressing on chronic wounds with no clinical signs of infection. J Wound Care 13(10): 419, 421-423
51. White RJ (2001) A charcoal dressing with silver in wound infection: clinical evidence. Br J Community Nurs 6(12): Silver Supp 2
52. Wolcott RD, Rhoads DD, Dowd SE (2008) Biofilms and chronic wound inflammation. J Wound Care 17(8): 333-341
53. Wunderlich U, Orfanos CE (1991) Treatment of venous leg ulcers with silver-impregnated xerodressings. Hautartz 42: 446-450
54. Xu L, McLennan SV, Lo L, Natfaji A et al (2007) Bacterial load predicts healing rate in neuropathic diabetic foot ulcers. Diabetes Care 30(2): 378-380 (Pubitemid 46198351)
55. Young CV (2005) The effects of malodorous fungating malignant wounds on body image and quality of life. J Wound Care 14(8): 359-362
56. Zamboni P, Lanzara S, Mascoli F, Caggiati A, Liboni A (2008) Inflammation in venous disease. Int Angiol 27(5): 361-369